Literature DB >> 27625049

Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.

Marika Saarela1, Satu Mustanoja1, Johanna Pekkola2, Tiina Tyni3, Juha Hernesniemi4, Leena Kivipelto4, Turgut Tatlisumak1,5.   

Abstract

Background and purpose Moyamoya vasculopathy, a rare steno-occlusive progressive cerebrovascular disorder, has not been thoroughly studied in Caucasian populations. We established a registry of Finnish patients treated at the Helsinki University Hospital, to collect and report demographic and clinical data. Methods We collected data both retrospectively and prospectively from all the patients with a moyamoya vasculopathy referred to our hospital between January 1987 and December 2014. All patients underwent a neurological outpatient clinic visit. Results We diagnosed 61 patients (50 females, 10 children) with moyamoya vasculopathy. The mean age at the disease-onset was 31.5 ± 17.9 years. The two most common presenting symptoms were ischemic stroke (n = 31) and hemorrhage (n = 8). Forty-four percent underwent revascularization surgery, and 70% were prescribed antithrombotic treatment. Conclusions The results support in part the Western phenotype of the disease considering the later presentation and larger female predominance compared to the Asian moyamoya vasculopathy reports. However, the proportion of ischemic strokes and hemorrhagic strokes is closer to Japanese population than German population. The absence of familial cases points to a different genetic profile in the Finnish patients.

Entities:  

Keywords:  Moyamoya; clinical characteristics; epidemiology; hemorrhagic stroke; ischemic stroke; vasculopathy

Mesh:

Substances:

Year:  2016        PMID: 27625049     DOI: 10.1177/1747493016669847

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  5 in total

1.  Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery.

Authors:  Ronan J Doherty; John Caird; Darach Crimmins; Peter Kelly; Sean Murphy; Christopher McGuigan; Niall Tubridy; Mary D King; Bryan Lynch; David Webb; Desmond O'Neill; Dominick J H McCabe; Peter Boers; Mary O'Regan; Joan Moroney; David J Williams; Simon Cronin; Mohsen Javadpour
Journal:  Ir J Med Sci       Date:  2020-06-19       Impact factor: 1.568

2.  Moyamoya angiopathy: radiological follow-up findings in Finnish patients.

Authors:  Marika Savolainen; Johanna Pekkola; Satu Mustanoja; Tiina Tyni; Juha Hernesniemi; Leena Kivipelto; Turgut Tatlisumak
Journal:  J Neurol       Date:  2020-04-22       Impact factor: 4.849

3.  Moyamoya Disease May Mimic Multiple Sclerosis?

Authors:  Ioanna Spanou; Maria-Eleftheria Evangelopoulos; Georgios Velonakis; Nikolaos Logiotatos; Achilleas Chatziioannou; Constantinos Potagas; Constantinos Kilidireas; Sophia Vassilopoulou
Journal:  Case Rep Neurol Med       Date:  2019-05-02

4.  Current trends in pediatric moyamoya: a survey of international practitioners.

Authors:  Harishchandra Lalgudi Srinivasan; Moran Hausman-Kedem; Edward R Smith; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2021-03-10       Impact factor: 1.475

5.  Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.

Authors:  Yixin Sun; Guoyu Zhou; Jingnan Feng; Lu Chen; Guozhen Liu; Jinxi Wang; Qingliang Wang; Junyou Yu; Xiwang Yang; Zheng Yang; Pei Gao; Shengfeng Wang; Siyan Zhan
Journal:  Stroke Vasc Neurol       Date:  2021-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.